Concurrent Speaker :
Kevin C. Halling, MD, PhD
Co-Director of the Clinical Molecular Genetics Laboratory / Consultant, Divisions of Laboratory Genetics and Clinical Genomics
Laboratory Medicine and Pathology
Kevin C. Halling, MD, PhD is a molecular pathologist and a Professor in Mayo Clinic’s Department of Laboratory Medicine in Rochester, MN. He is a co-director of the Genomics Laboratory which performs molecular oncology and hereditary disorder testing. He completed a PhD in Biochemistry and an MD at the University of Kansas. Then he did an Anatomic and Clinical pathology residency and Clinical Molecular Genetics fellowship at the Mayo Clinic. His primary area of interest is in the development of genetic tests that can be used for the diagnosis and treatment of sporadic and hereditary cancer. He and his team have developed a clinical RNA Seq assay that can be used to detect gene fusions in patients with various types of malignancies and are also working on other clinical applications of RNA-seq and other RNA testing methodologies such as Nanostring. Dr. Halling has published over 100 papers that mostly relate to genetic testing of cancer.